26 completed. 26 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 26 | Completed 26 |
Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Bioequivalence of Micafungin (50mg/Vial) Micafungin - Invasive Candidiasis | Phase 4 | Completed | Yung Shin Pharm. Ind. Co., Ltd. | 14 | 2022-01-06 | 2022-08-11 |
| Study of Lactobacillus in Adjuvant Treatment of RVVC clotrimazole vaginal tablets, Clotrimazole vaginal tablets+ Lactobacillus - Recurrent Vulvovaginal Candidiasis | Phase 4 | Completed | Peking University Shenzhen Hospital | 140 | 2020-07-01 | 2025-06-12 |
| Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration Fluconazole 200mg tab, Fluconazole 2 MG/ML - Fluconazole, Candidiasis | Phase 4 | Completed | Radboud University Medical Center | 25 | 2019-11-30 | 2021-07-14 |
| Evaluation of Efficacy and Safety of Gynomax® XL Ovule Gynomax® XL Vaginal Ovule - Trichomonal Vaginitis, Bacterial Vaginosis | Phase 4 | Completed | Exeltis Turkey | 116 | 2019-04-03 | 2020-01-31 |
| Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections Boric acid and probiotics, Antibiotic (Clindamycin), Antifungal (Clotrimazole) - Candidiasis, Vaginosis, Bacterial | Phase 4 | Completed | Laboratorios Ordesa | 48 | 2016-07-12 | 2019-11-19 |
| Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis Fluomizin vaginal tablets, Canesten vaginal tablets - Vulvovaginal Candidiasis | Phase 4 | Completed | Medinova AG | 150 | 2014-11-01 | 2016-09-15 |
| Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Clotrimazole vaginal tablet, Fluconazole - Candidiasis, Vulvovaginal | Phase 4 | Completed | Peking University Shenzhen Hospital | 240 | 2014-07-01 | 2017-05-02 |
| Pharmacokinetics of Micafungin in Patients of Intensive Care Units micafungin - Invasive Candidiasis | Phase 4 | Completed | University Hospital, Limoges | 60 | 2014-06-01 | 2025-11-21 |
| Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Terconazole Vaginal Suppository, Fluconazole - Vulvovaginal Candidiasis | Phase 4 | Completed | Peking University Shenzhen Hospital | 140 | 2013-08-01 | 2020-10-23 |
| Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Clotrimazole - Candidiasis, Vulvovaginal | Phase 4 | Completed | Instituto Palacios | 56 | 2013-06-01 | 2015-03-25 |
| Negative Beta Glucan in ICU Patients Anidulafungin - Candidemia | Phase 4 | Completed | Universidade Federal do Rio de Janeiro | 85 | 2012-11-01 | 2019-07-08 |
| Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections ClinSupV3 -soft gelatin capsule, ClinSupV3ER- Extended release tablet - Vaginal Infections | Phase 4 | Completed | Dr Bharti Daswani | 73 | 2011-04-01 | 2012-10-02 |
| An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis Miconazole plus Hydrocortisone - Vulva; Candidiasis | Phase 4 | Completed | Janssen Pharmaceutica | 115 | 2009-01-01 | 2013-03-25 |
| Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins micafungin, Micafungin, Caspofungin - Candidemia | Phase 4 | Completed | Gary E. Stein, Pharm.D. | 21 | 2008-12-01 | 2024-04-30 |
| Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients Nystatin - Fungal Prophylaxis, Candida Infection | Phase 4 | Completed | Policlinico Hospital | 99 | 2008-11-01 | 2017-04-05 |
| A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects anidulafungin and voriconazole - Aspergillosis, Candidemia | Phase 4 | Completed | Pfizer | 24 | 2008-09-01 | 2010-02-09 |
| This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis Anidulafungin, Voriconazole - Candidemia, Invasive Candidiasis | Phase 4 | Completed | Pfizer | 54 | 2008-02-01 | 2011-01-17 |
| Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Caspofungin, Normal Saline - Invasive Candidiasis | Phase 4 | Completed | Mycoses Study Group | 222 | 2007-08-01 | 2011-05-09 |
| Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis Eraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole) - Candidiasis | Phase 4 | Completed | Pfizer | 282 | 2007-07-01 | 2011-10-03 |
| CRITIC - Treatment of Candidemia and Invasive Candidiasis AmBisome - Candidemia, Invasive Candidiasis | Phase 4 | Completed | Gilead Sciences | 39 | 2007-05-01 | 2009-03-27 |
Showing 20 of 26. Sign in to see all of them.
Candidiasis, Vulvovaginal (7) · Candidemia (6) · Candidiasis, Invasive (6) · Candidiasis, Oral (3) · Vaginosis, Bacterial (3) · Aspergillosis (2) · Mycoses (2) · AIDS-Related Opportunistic Infections (1) · Acquired Immunodeficiency Syndrome (1) · Asthma (1) · Critical Illness (1) · Cryptococcosis (1) · HIV Infections (1) · Invasive Fungal Infections (1)
Bacterial Infections and Mycoses (26) · Infections (26) · Mycoses (24) · Genital Diseases (11) · Urogenital Diseases (11) · Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases, Female (9) · Invasive Fungal Infections (9) · Pathological Conditions, Signs and Symptoms (9) · Vaginal Diseases (9) · Vaginitis (8) · Pathologic Processes (7) · Vulvar Diseases (7)
Fluconazole (7) · Anidulafungin (4) · Clotrimazole (4) · Voriconazole (4) · Micafungin (3) · Caspofungin (2) · Clindamycin (2) · Miconazole (2) · liposomal amphotericin B (2) · Anti-Bacterial Agents (1) · Antifungal Agents (1) · Fluticasone (1) · Hydrocortisone (1) · Magnetic Resonance Spectroscopy (1) · Nystatin (1)
Pfizer (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Peking University Shenzhen Hospital (3) · Allergy & Asthma Medical Group & Research Center (1) · Dr Bharti Daswani (1) · Exeltis Turkey (1) · Gary E. Stein, Pharm.D. (1) · Gilead Sciences (1) · Instituto Palacios (1) · Janssen Pharmaceutica (1) · Laboratorios Ordesa (1) · Medinova AG (1) · Mycoses Study Group (1) · Policlinico Hospital (1) · Radboud University Medical Center (1)
United States (9) · China (3) · Brazil (2) · Italy (2) · Spain (2) · Taiwan (2) · Chile (1) · Colombia (1) · France (1) · India (1) · Mexico (1) · Netherlands (1) · Panama (1) · Puerto Rico (1) · South Korea (1)
Shangrong Fan, M.D. (3) · Bharti R Daswani, MD, PhD (1) · Eli O Meltzer, MD (1) · Filomena Puntillo, Professor (1) · Francesco Bruno, Professor (1) · Gary E Stein, Pharm.D. (1) · Juan A Tena, Dr. (1) · Kurt T Barnhart, MD, MSCE (1) · Luigi Picaro (1) · Luis Ostrosky-Zeichner, MD (1) · Manopchai Thamkhantho, Prof MD (1) · Marcio Nucci, MD (1) · Mitchell Goldman (1)
PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293, PMID 19144094, PMID 22490643, PMID 23710653, PMID 24550378, PMID 24559321, PMID 25877666, PMID 27073145, PMID 27287231, PMID 32940765, PMID 41219680